Clinical trial
Rosiglitazone Versus Theophylline in Asthmatic Smokers
NCT00119496 · University of Glasgow, Other · Completed
Key facts
| NCT number | NCT00119496 |
|---|---|
| Title | Rosiglitazone Versus Theophylline in Asthmatic Smokers |
| Official title | A Clinical Study to Investigate the Effect of Rosiglitazone, Theophylline and Inhaled Corticosteroid, Inflammation and Pulmonary Function in Asthmatic Smokers |
| Lead sponsor | University of Glasgow, Other |
| Collaborators | GlaxoSmithKline Industry Chest, Heart and Stroke Association Scotland Chief Scientist Office of the Scottish Government |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | rosiglitazone, theophylline, beclomethasone, inhaled beclomethasone and oral theophylline |
| Enrollment | 79 |
| Start date | Jul 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Jul 13, 2005 |
| Last update posted | Jan 27, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: